A Phase 2 multi-center, investigator masked, 28-day, parallel group, dose-finding study of NCX-470 in adult subjects with elevated intraocular pressure (IOP) due to open-angle glaucoma or ocular hypertension

Trial Profile

A Phase 2 multi-center, investigator masked, 28-day, parallel group, dose-finding study of NCX-470 in adult subjects with elevated intraocular pressure (IOP) due to open-angle glaucoma or ocular hypertension

Planning
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2017

At a glance

  • Drugs NCX 470 (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus First in man; Therapeutic Use
  • Most Recent Events

    • 24 Oct 2017 According to a Nicox media release, IND filling is anticipated in the first half of 2018.
    • 24 Jan 2017 According to a Nicox media release, based on the feedback from meeting with the U.S. FDA conducted at the end of 2016, company is finalizing the design of this trial. IND filling is anticipated in Q4 2017 and an enrolment is expected to begin in early 2018 (Q1 2018).
    • 05 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top